thomsen-friedenreich antigen has been researched along with tamoxifen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Cheng, RC; Goletz, S; Karsten, U; Lin, WM | 1 |
1 other study(ies) available for thomsen-friedenreich antigen and tamoxifen
Article | Year |
---|---|
Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
Topics: AC133 Antigen; Adenocarcinoma; Antigens, CD; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Cell Count; Cell Line, Tumor; Female; Flow Cytometry; Glycoproteins; GPI-Linked Proteins; Humans; Hyaluronan Receptors; Immunohistochemistry; Isoantigens; Liver Neoplasms; Lung Neoplasms; Neoplastic Stem Cells; Peptides; Receptors, Cell Surface; Tamoxifen | 2011 |